Drug–Drug Interactions of Newly Approved Direct-Acting Antiviral Agents in Patients with Hepatitis C

Hepatitis C is a major health problem worldwide, frequently resulting in cirrhosis and increasing the risk of hepatocellular carcinoma significantly. In recent years, the advent of direct-acting antivirals (DAAs) has dramatically improved the therapeutic outcomes in hepatitis C patients. In the last...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Lu-Hua, Nie, Qing-He, Zhao, Xi-Tai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850569/
https://www.ncbi.nlm.nih.gov/pubmed/33536776
http://dx.doi.org/10.2147/IJGM.S283910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850569/
https://www.ncbi.nlm.nih.gov/pubmed/33536776
http://dx.doi.org/10.2147/IJGM.S283910

Ejemplares similares